Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Pramlintide fda approval date?Is allopurinol expensive?When will generic fiasap insulin be available?Patent term adjustment semaglutida?
See the DrugPatentWatch profile for dupixent
Dupixent (dupilumab) is an injected medicine whose active ingredient is dupilumab, a laboratory-made (recombinant) monoclonal antibody. [1]
Because dupilumab is a monoclonal antibody, Dupixent is made from engineered protein material that is designed to bind specific parts of the immune system (it targets the IL-4 and IL-13 signaling pathway). [1]
Dupixent is a biologic (not a small-molecule pill). It’s delivered as a drug product containing the monoclonal antibody dupilumab. [1]
DrugPatentWatch.com lists Dupixent and its details, which can help you confirm the medicine’s identity (dupilumab) and related information. [1]
Other Questions About Dupixent :